Aleksandra  Krusko net worth and biography

Aleksandra Krusko Biography and Net Worth

SVP of Cencora
Aleks Krusko is the Senior Vice President of Information Technology and Digitization at CoreSite. She is responsible for the execution of CoreSite’s digital strategies through technology, automation and business transformation. She leads the IT Solutions Delivery and IT Operations teams, including: software development, system support, information security and business intelligence. Aleks joined CoreSite in 2008. Before her current role, Aleks spearheaded the delivery of system and process efficiencies, change management and architected cross-functional solutions across the organization. Prior to joining CoreSite, Aleks held various roles of increasing responsibility in the Real Estate industry. She earned a B.S. in Chemistry, with honors, from Regis University.

How do I contact Aleksandra Krusko?

The corporate mailing address for Ms. Krusko and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Aleksandra Krusko's contact information.

Has Aleksandra Krusko been buying or selling shares of Cencora?

Aleksandra Krusko has not been actively trading shares of Cencora over the course of the past ninety days. Learn More on Aleksandra Krusko's trading history.

Who are Cencora's active insiders?

Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.

Are insiders buying or selling shares of Cencora?

During the last year, insiders at the sold shares 21 times. They sold a total of 7,622,034 shares worth more than $1,640,810,686.31. The most recent insider tranaction occured on April, 16th when CEO Steven H Collis sold 10,754 shares worth more than $2,553,859.92. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.

Information on this page was last updated on 4/16/2024.

Aleksandra Krusko Insider Trading History at Cencora

See Full Table

Aleksandra Krusko Buying and Selling Activity at Cencora

This chart shows Aleksandra Krusko's buying and selling at Cencora by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cencora Company Overview

Cencora logo
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $239.97
Low: $238.25
High: $241.05

50 Day Range

MA: $238.24
Low: $231.72
High: $245.77

2 Week Range

Now: $239.97
Low: $163.37
High: $246.75

Volume

563,320 shs

Average Volume

1,256,139 shs

Market Capitalization

$47.87 billion

P/E Ratio

26.14

Dividend Yield

0.86%

Beta

0.45